JS
Jayesh Shantilal Shah
About Jayesh Shantilal Shah
Data last updated:
Jayesh Shantilal Shah is a Whole-Time Director at Intas Pharmaceuticals Limited (since 2018), Director at One Advertising And Communication Services Limited (since 2009) and Director at Sm Herbals Private Limited (since 2019), and holds 1 more current directorship. The companies operate in Pharma, Media and Publishing and Healthcare. The 3 current companies with reported revenue have a combined latest revenue of ₹21,342 Cr; the largest is Intas Pharmaceuticals Limited at ₹21,241 Cr (FY 2025). Earlier, Jayesh Shantilal Shah was a Director at Penem Pharmachemi Private Limited (2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Intas Pharmaceuticals Limited U24231GJ1985PLC007866 | Whole-Time Director | 21 Mar 2018 | 1985 | ₹21,241 Cr (FY 2025) | Active |
 One Advertising And Communication Services Limited U74300GJ2001PLC046472 | Director | 02 Feb 2009 | 2001 | ₹61.06 Cr (FY 2025) | Active |
 Sm Herbals Private Limited U18101GJ1993PTC114239 | Director | 01 Nov 2019 | 1993 | ₹39.59 Cr (FY 2023) | Active |
 Abcd Technologies Llp AAV-8269 | Partner | 30 Apr 2021 | 2021 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Penem Pharmachemi Private Limited U46909MH2023PTC402560 | Director | 09 May 2023 | 2023 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Jayesh Shantilal Shah
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jayesh Shantilal Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jayesh Shantilal Shah
Jayesh Shantilal Shah currently holds 4 directorships: Intas Pharmaceuticals Limited (Whole-Time Director, since 21 Mar 2018, revenue ₹21,241 Cr (FY 2025)); One Advertising And Communication Services Limited (Director, since 02 Feb 2009, revenue ₹61.06 Cr (FY 2025)); Sm Herbals Private Limited (Director, since 01 Nov 2019, revenue ₹39.59 Cr (FY 2023)); Abcd Technologies Llp (Partner, since 30 Apr 2021).
Jayesh Shantilal Shah was first appointed on 02 Feb 2009 as Director at One Advertising And Communication Services Limited. The most recent appointment on record is 09 May 2023 at Penem Pharmachemi Private Limited.
The 3 current companies of Jayesh Shantilal Shah that report revenue have a combined latest revenue of ₹21,342 Cr: Intas Pharmaceuticals Limited ₹21,241 Cr (FY 2025); One Advertising And Communication Services Limited ₹61.06 Cr (FY 2025); Sm Herbals Private Limited ₹39.59 Cr (FY 2023).
Jayesh Shantilal Shah held 1 earlier board appointment: Penem Pharmachemi Private Limited (Director, 09 May 2023 to 07 Jun 2023).
The current boards of Jayesh Shantilal Shah's companies include Archana Ravindrarai Dholakia (Intas Pharmaceuticals Limited), Binish Hasmukh Chudgar (Intas Pharmaceuticals Limited), Hasmukh Chudgar (Intas Pharmaceuticals Limited), Jitesh Kishorekumar Gadhia (Intas Pharmaceuticals Limited), Manoj Narayanan Nair (Intas Pharmaceuticals Limited), Nimish Chudgar (Intas Pharmaceuticals Limited), among others.